|4Feb 5, 9:54 PM ET

Kindred Biosciences, Inc. 4

4 · Kindred Biosciences, Inc. · Filed Feb 5, 2014

Insider Transaction Report

Form 4
Period: 2014-02-03
GALLIKER STEPHEN S
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2014-02-03+50,00050,000 total
    Exercise: $15.41Exp: 2024-02-03Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The option will vest as to 50% upon date of grant and 50% on February 3, 2015.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT